Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: The importance of tumor length and lymph node status

Cancer

Volumn 95, Issue 7, 2002, Pages 1434-1443

  Eloubeidi, Mohamad A ^a,b   Desmond, Renee ^b   Arguedas, Miguel R ^a   Reed, Carolyn E ^c   Wilcox, C Mel ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Esophageal carcinoma; Lymph node status; Survival; Tumor length

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; UNITED STATES;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 0036785408     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10868     Document Type: Article

References (17)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. Ca Cancer J Clin. 2001;51:15-36.
2. Lightdale CJ. Esophageal cancer. Am J Gastroenterol. 1999;94:20-29.
3. Rice TW, Adelstein DJ. Precise clinical staging allows treatment modification of patients with esophageal carcinoma. Oncology (Huntingt). 1997;11:58-62.
4. Japanese Committee for Registration of Esophageal Carcinoma. A proposal for a new TNM classification of esophageal carcinoma. Jpn J Clin Oncol. 1985;15:625-636.
5. Korst RJ, Rusch VW, Venkatraman E, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg. 1998;115:660-669.
6. Nigro JJ, DeMeester SR, Hagen JA, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999;117:960-968.
7. Steup WH, De LP, Deneffe G, et al. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111:85-94.
8. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia [see comments]. JAMA. 1991;265:1287-1289.
9. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993;270:1320.
10. American Joint Committee on Cancer. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven, 2000:65-68.
11. Percy C, Van Holten V, Muire C. International classification of diseases for oncology, 2nd ed. Geneva: World Health Organization, 1990.
12. National Cancer Statistics Branch. Surveillance, Epidemiology and End Results (SEER) Program: public-use CD-ROM (1973-1997). Bethesda: National Cancer Statistics Branch, 2000.
13. Rice TW, Blackstone EH, Adelstein DJ, et al. N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg. 2001;121:454-464.
14. Rice TW, Zuccaro GJ, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787-792.
15. Burtin P, Kaassis M, Aube K, et al. ASA classification and lymph node extent at endosonography are independent predictive factors of survival of patients with esophageal cancer [abstract]. Gastrointest Endosc. 2000;51:AB119.
16. Christie NA, Rice TW, DeCamp MM, et al. Mla/Mlb esophageal carcinoma: clinical relevance. J Thorac Cardiovasc Surg. 1999;118:900-907.
17. Eloubeidi MA, Wallace MB, Hoffman BJ, et al. Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography. Ann Thorac Surg. 2001;72:212-219.